the aid library

LIST OPTIONS

Filter

5099

Sort by:

Direction:

Download (416)

View PDF (578)

National Strategy for Rural Water Supply, Sanitation and Hygiene (WASH), WASH in Schools and WASH in Health Facilities 2016 - 2030

Government of the Republic of the Union of Myanmar (2016) C1

The purpose of this Strategy is to set out the way to meet the needs of the rural populations for improved domestic water supply services, access to and use of improved sanitation with elimination of open defecation, and improved hygiene behaviour by the Year 2030. It also addresses water, sanitatio... more

Download (107)

View PDF (156)

Young people and the law in Asia and the Pacific: a review of laws and policies affecting young people's access to sexual and reproductive health and HIV services

UNESCO Office Bangkok and Regional Bureau for Education in Asia and the Pacific United Nations Educational, Scientific and Cultural Education; UNFPA; UNAIDS; UNDP; Youth Lead (2013) C2

Download (987)

View PDF (2426)

Hunger-Nutrition-Climate Justice-2013 - A new Dialogue: Putting People at the Heart of Global Development

Irish Aid, WFP, CCAFS Coordinating Unit, Mary Robinson Foundation - Climate Justice Irish Aid (2013) CC

Confernece Report 15-16 April 2013 - Dublin, Ireland

Download (159)

View PDF (131)

COVID-19 Planning Guide for Adapting Risk Communication and Community Engagement as Public Health and Social Measures Shift

IFRC; Save the Children andJohn Hopkins Center for Communication Programs (2020) CC

With Safety Tips for Conducting Community Meetings Updated July 2020 This document includes key Risk Communication and Community Engagement (RCCE) considerations during shifting lockdown measures, safety measures for conducting in-person community meetings, and a template that brings both of these... more

Download (128)

View PDF (186)

A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens includin

Dheda, K.; et al. (2022) CC

Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173

Download (308)

View PDF (134)

Manual for the laboratory diagnosis and virological surveillance of influenza

World Health Organization WHO (2011) C_WHO

Download (29)

View PDF (27)

Effectiveness of a Diabetes Program based on eHealth on capacity building and quality of care in type 2 diabetes: a pragmatic quasi-experimental study.

Moraes Morelli, D. Institute for Clinical Effectiveness and Health Policy (2022) CC2

Diabetes Burdens: 10.5% adults around the world are currently loving with diabetes.

Download (83)

View PDF (110)

Руководство по использованию цифровых технологий для обеспечения соблюдения режима приема противотуберкулезных препаратов

World Health Organization WHO (2017) C_WHO

Одним из важных применений цифрового здравоохранения в уходе за больными туберкулезом является поддержка, которую он может оказать в соблюдении режима приема лек... more

Download (135)

View PDF (204)

Всесвітня організація охорони здоров’я. Інструмент самодопомоги з планування людиноорієнтованого процесу відновлення психічного здоров’я та благополуччя. Ініціатива ВООЗ QualityRights

World Health Organization WHO (2022) C_WHO

Навчальні та методичні модулі ініціативи ВООЗ QualityRights було розроблено з метою покращення знань, навичок та розуміння ключових зацікавлених сторін про те, як сприя�... more

Download (205)

View PDF (110)

WHO Emergency Response Framework - Internal WHO procedures - Second Edition

World Health Organization WHO (2024) C_WHO

The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a... more

Download (73)

View PDF (432)

Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures

World Health Organization WHO (2016) C_WHO

Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th... more

Download (149)

View PDF (149)

Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization

World Health Organization WHO (2019) C_WHO

Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization

Download (247)

View PDF (333)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (242)

View PDF (128)

WHO recommended standards and strategies for surveillance, prevention and control of communicable diseases

World Health Organization WHO (2001) C_WHO

Communicable diseases are a major cause of suffering, disability and death in the world. The World Health Organization’s Programme on Communicable Diseases provides technical guidance and support to national governments to organize and implement programmes aimed at setting up or strengthening ong... more

Download (97)

View PDF (129)

Уход на дому за пациентами с подозрением на заражение или подтвержденным заболеванием COVID-19 и тактика ведения контактных лиц
recommended

World Health Organization WHO (2020) C_WHO

Этот документ представляет собой обновление рекомендаций «Уход на дому за пациентами с легкой формой заболевания COVID‑19 и тактика ведения контактных лиц», опубл�... more

Download (90)

View PDF (117)

"Peticiones" al sector privado en respuesta a la COVID-19

World Health Organization WHO (2020) C_WHO

Los "peticiones" se han preparado para que las empresas privadas tomen medidas concretas en la pandemia de COVID19.

Download (78)

View PDF (100)

Ce que le secteur privé peut fairepour riposter à la COVID-19

World Health Organization WHO (2020) C_WHO

Les "demandes" ont été préparées pour que les entreprises privées prennent des mesures concrètes face à la pandémie de COVID19.

Download (126)

View PDF (148)

Community-Based Child Protection Mechanisms in Refugee Camps in Rwanda: An Ethnographic Study

Child Protection in Crisis Network for Research, Learning & Action (2013) CC

Despite the increasing population of refugees stuck in protracted situations and our awareness of the vulnerability of children and adolescents growing in up these contexts, relatively little is known about community based child protection mechanisms (CBCPMs) in refugee communities. CBCPMs, defined ... more

Download (26)

View PDF (28)

Sharing successful strategies from the Eastern Mediterranean Region in mitigating noncommunicable diseases and mentalhealth disorders during the COVID-19pandemic and beyond

World Health Organization (WHO) Regional Office for the Eastern Mediterranean World Health Organization (WHO) Regional Office for the Eastern Mediterranean (2023) C_WHO

The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularly during the COVID-19 pandemic. It highlights regio... more

Download (211)

View PDF (181)

A checklist for respiratory pathogen pandemic preparedness planning

World Health Organization WHO (2023) C_WHO

This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.

Уход на дому за пациентами с подозрением на заражение или подтвержденным заболеванием COVID-19 и тактика ведения контактных лиц recommended

Уход на дому за пациентами с подозрением на заражение или подтвержденным заболеванием COVID-19 и тактика ведения контактных лиц
recommended